Cardlytics, INC Form 4 insider transactions
NASDAQ
CDLX
Cardlytics, INCCardlytics CFO Alexis DeSieno sold 26,048 shares of common stock at a weighted average price of $1.217 to cover tax obligations following the vesting of 43,750 restricted stock units.
NASDAQ
CDLX
Cardlytics, INCCardlytics CEO Amit Gupta reported the vesting of 14,349 restricted stock units and the subsequent sale of 6,725 shares to cover tax withholding obligations.
NASDAQ
CDLX
Cardlytics, INCCardlytics Chief Financial Officer Alexis DeSieno reported the acquisition of 14,349 common shares through restricted stock unit vesting and the subsequent sale of 7,324 shares at a weighted average price of $1.7826 to cover tax obligations.
NASDAQ
CDLX
Cardlytics, INCCardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reported the vesting of restricted stock units and a subsequent sale of shares solely to cover tax obligations.
NASDAQ
CDLX
Cardlytics, INCForm 4: Cardlytics Director Clifford Sosin Reports Internal Distribution of Shares and Convertible Notes
Clifford Sosin, a Director and 10% owner of Cardlytics, Inc., reported pro rata distributions of common stock and convertible senior notes to partners of investment vehicles he manages, with no consideration exchanged.
NASDAQ
CDLX
Cardlytics, INCCardlytics, Inc. Chief Financial Officer Alexis DeSieno was granted 55,000 contingent equity awards, comprising Restricted Stock Units and Performance Stock Units, aligning her interests with shareholder value.
NASDAQ
CDLX
Cardlytics, INCCardlytics, Inc. (CDLX) has granted its Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, 25,000 Restricted Stock Units (RSUs) and 9,375 Performance Stock Units (PSUs) as part of his compensation.
NASDAQ
CDLX
Cardlytics, INCCardlytics, Inc. has granted its Chief Executive Officer and Director, Amit Gupta, a total of 1.3 million contingent equity units, comprising Restricted Stock Units and Performance Stock Units, as part of his compensation.
NASDAQ
CDLX
Cardlytics, INCDirector Scott A. Hill reports the vesting and conversion of restricted stock units into Cardlytics common stock.
NASDAQ
CDLX
Cardlytics, INCDirector Liane Hornsey reports the vesting and conversion of restricted stock units into 11,000 shares of Cardlytics (CDLX) common stock on May 23, 2025.
NASDAQ
CDLX
Cardlytics, INCDirector Jonathan Edward Francis reports the vesting and conversion of restricted stock units into common stock.
NASDAQ
CDLX
Cardlytics, INCDirector John L. Klinck Jr. reports the vesting and conversion of restricted stock units into Cardlytics common stock.
NASDAQ
CDLX
Cardlytics, INCDirector Andre J. Fernandez reports the vesting and disposal of 11,000 restricted stock units into Cardlytics common stock on May 23, 2025.
NASDAQ
CDLX
Cardlytics, INCDirector Andre J. Fernandez acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date.
NASDAQ
CDLX
Cardlytics, INCDirector John L. Klinck Jr. reports acquisition of 11,000 restricted stock units in Cardlytics, Inc.
NASDAQ
CDLX
Cardlytics, INCDirector Jonathan Edward Francis acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, according to a Form 4 filing.
NASDAQ
CDLX
Cardlytics, INCDirector Liane Hornsey acquired 11,000 restricted stock units (RSUs) of Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date, provided she remains a director.
NASDAQ
CDLX
Cardlytics, INCDirector Scott A. Hill acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date.
NASDAQ
CDLX
Cardlytics, INCDirector Srishti A. Gupta acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date.
NASDAQ
CDLX
Cardlytics, INCCardlytics' Chief Financial Officer, Alexis DeSieno, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.
NASDAQ
CDLX
Cardlytics, INCCardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
CDLX
Cardlytics, INCDirector Liane Hornsey reports the vesting of restricted stock units into Cardlytics common stock.
NASDAQ
CDLX
Cardlytics, INCCardlytics CEO Amit Gupta reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
CDLX
Cardlytics, INCCardlytics' Chief Financial Officer, Alexis DeSieno, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
CDLX
Cardlytics, INCCardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
CDLX
Cardlytics, INCCardlytics' Chief Financial Officer, Alexis DeSieno, was granted performance-based and time-based restricted stock units on March 19, 2025.
NASDAQ
CDLX
Cardlytics, INCChief Legal & Privacy Officer of Cardlytics, Inc., Nicholas Hollmeyer Lynton, reports the acquisition of performance stock units and restricted stock units.
NASDAQ
CDLX
Cardlytics, INCCardlytics CEO Amit Gupta sold shares of common stock to cover tax obligations resulting from the vesting of restricted stock units (RSUs).
NASDAQ
CDLX
Cardlytics, INCCardlytics' Chief Financial Officer, Alexis DeSieno, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
CDLX
Cardlytics, INCCardlytics' Chief Legal & Privacy Officer, Nicholas Lynton, reports the acquisition of 6,312 shares through performance stock units and the subsequent sale of 3,377 shares to cover tax obligations.